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Abstract
Background: Depression is the most prevalent cause of illness-induced disability worldwide. Face-to-face psychotherapeutic
interventions for depression can be challenging, so there is a need for other alternatives that allow these interventions to be offered.
One feasible alternative is Internet-based psychological interventions. This is the first randomized controlled trial (RCT) on the
effectiveness of an Internet-based intervention on depression in primary health care in Spain.
Objective: Our aim was to compare the effectiveness of a low-intensity therapist-guided (LITG) Internet-based program and a
completely self-guided (CSG) Internet-based program with improved treatment as usual (iTAU) care for depression.
Methods: Multicenter, three-arm, parallel, RCT design, carried out between November 2012 and January 2014, with a follow-up
of 15 months. In total, 296 adults from primary care settings in four Spanish regions, with mild or moderate major depression,
were randomized to LITG (n=96), CSG (n=98), or iTAU (n=102). Research completers at follow-up were 63.5%. The intervention
was Smiling is Fun, an Internet program based on cognitive behavioral therapy. All patients received iTAU by their general
practitioners. Moreover, LITG received Smiling is Fun and the possibility of psychotherapeutic support on request by email,
whereas CSG received only Smiling is Fun. The main outcome was the Beck Depression Inventory-II at 3 months from baseline.
Mixed-effects multilevel analysis for repeated measures were undertaken.
Results: There was no benefit for either CSG [(B coefficient=-1.15; P=.444)] or LITG [(B=-0.71; P=.634)] compared to iTAU,
at 3 months. There were differences at 6 months [iTAU vs CSG (B=-4.22; P=.007); iTAU vs LITG (B=-4.34; P=.005)] and 15
J Med Internet Res 2016 | vol. 18 | iss. 8 | e231 | p.1http://www.jmir.org/2016/8/e231/
(page number not for citation purposes)
Montero-Marín et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
months [iTAU vs CSG (B=-5.10; P=.001); iTAU vs LITG (B=-4.62; P=.002)]. There were no differences between CSG and
LITG at any time. Adjusted and intention-to-treat models confirmed these findings.
Conclusions: An Internet-based intervention for depression combined with iTAU conferred a benefit over iTAU alone in the
Spanish primary health care system.
Trial Registration: Clinicaltrials.gov NCT01611818; https://register.clinicaltrials.gov/prs/app/action/SelectProtocol?
selectaction=Edit&uid=U0001NPQ&ts=2&cx=gctdh2&sid=S0003KJ6 (Archived by WebCite at
http://www.webcitation.org/6jbsUvUDz)
(J Med Internet Res 2016;18(8):e231)   doi:10.2196/jmir.5695
Introduction
Depression is the most prevalent cause of illness-induced
disability worldwide [1]. It is among the most common reasons
for consulting a general practitioner (GP), and it carries
considerable personal and economic burden [2]. Antidepressants
are a common form of treatment for depressive patients in
primary care (PC) [3], but many patients would also like to
receive psychotherapy [4]. Psychological treatments for
depression are shown to be effective in PC, especially when
GPs refer patients for treatment [5]. There is evidence that
psychological treatments achieve results as effective as those
achieved by antidepressant medication, reducing the number of
physician consultations and hospital days, and obtaining better
results in adherence, relapse prevention, and reducing chronicity
[6].
Nevertheless, delivering face-to-face psychotherapeutic
interventions to a population is challenging given the lack of
specialized resources [7], so there is a need for other alternatives
that allow these interventions to be offered. One feasible
alternative is Internet-based psychological interventions [8].
The Internet offers a way of providing psychological treatments
for depression [9] that may even attract people who are reluctant
to use traditional mental health services [10] because of barriers
such as possible stigmatization processes [11]. In general,
Internet-based psychological treatments seem to be effective
for the treatment of depression. Although the effects seem to
be more favorable for guided or assisted interventions [12-14],
stand-alone Internet-based treatments for depression have also
shown to be effective [15].
Until now, there have been no studies on the effectiveness of
Internet-based treatments for depression in the context of PC
in Spain. Therefore, the main objective of this study was to
compare the effectiveness of a low-intensity therapist-guided
(LITG) Internet-based program and a completely self-guided
(CSG) Internet-based program with improved treatment as usual
(iTAU) care for the treatment of major depression in PC in
Spain.
Methods
Hypotheses
The main hypothesis was that both Internet-based interventions,
CSG and LITG, would be more effective in reducing depressive
symptoms than iTAU, in the context of PC at 3 months after
baseline. A secondary hypothesis was that, in the context of PC,
where there is a more frequent and closer contact with the GPs,
the offer of additional help is unlikely to improve outcomes
when using Internet-based interventions.
Design
This study was a multicenter, three-arm, parallel, randomized
controlled trial (RCT). Adults presenting with depressive
symptoms in PC were randomized to receive either iTAU from
their GP or an Internet-based intervention program (Smiling is
Fun) for depression, in this case, either with psychotherapist
support (LITG) or without it (CSG). The trial protocol of the
study [16], the manual used to implement the program [17], and
a study on expectations of depressed PC patients have already
been published [18,19].
Recruitment of Participants and Baseline Assessment
We recruited patients with major depression, aged 18-65 years,
able to understand and read Spanish, with mild or moderate
severity symptoms according to the Spanish Beck Depression
Inventory-II (BDI-II) (14-19: mild depression; 20-28: moderate
depression) [20], with symptoms lasting longer than 2 weeks,
with access to Internet at home, and having an email account.
Major depression was identified using the MINI International
Neuropsychiatric Interview 5.0, which can establish major
depression diagnoses according to the Diagnostic and Statistical
Manual, version IV (DSM-IV) and International Classification
of Diseases [21,22]. We excluded patients who had been
receiving any psychological treatment during the previous year,
those with severe psychiatric disorder in Axis I (eg,
alcohol/substances abuse or dependence, psychotic disorders,
dementia), and patients with severe depression (score ≥29 on
the BDI-II), who were referred by their GPs for treatment.
Participants were recruited in PC settings, between November
2012 and January 2014, in the Spanish regions of Aragon,
Andalusia, the Balearic Islands, and Valencia. GPs identified
potential participants through using a case-finding questionnaire.
Eligible individuals were then interviewed in the clinic within
the following 3 days by an independent researcher, who assessed
inclusion and exclusion criteria, using the MINI psychiatric
interview and other questionnaires. Informed consent to enter
the trial was sought from patients who fulfilled study criteria,
followed by randomization, carried out by an independent
researcher. Patient safety was systematically monitored. The
Ethical Review Board of the regional health authority approved
the study on April 7, 2010 (ref: PI10/01083).
Randomization, Concealment, and Blinding
Participants were individually randomized using blocked
randomization to one of the three groups. Blocks were
administered in each of the regions, using a computer-generated
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random number sequence. A person who had no other
involvement in the study managed the random allocation to
groups. This procedure was implemented through a remote
central telephone line. The sequence was concealed until all
individuals had been randomized. Although patients were not
informed of the group allocation, the nature of the intervention
meant that it was virtually impossible to keep this completely
blind. Study personnel conducting the outcome assessments
were blind to the participants’ allocation.
Follow-Up
Collection of follow-up data took place between March 2013
and June 2015. Participants were assessed online at 3 (time-1),
6 (time-2), and 15 (time-3) months post-baseline assessment.
These moments deviated from the registered protocol.
Post-treatment evaluation was stated at 3 months after the
beginning of the intervention in order not to favor participants
in the intervention conditions who could take longer than the
estimated intervention duration comparing to control group. By
setting the same evaluation moments for all participants, we
ensured that measurements would be comparable. Participants
were sent an email with a link to an online platform that hosted
the questionnaires. No other protocols were used to increase
compliance with the research data collection, but a phone call
was made before each wave assessment to increase response
rates.
Control Group
All the patients included in the study (whether in the control or
intervention arms) received iTAU. This treatment was provided
by their GPs, who had previously received a 3-hour training
program to update their knowledge on how to diagnose and
treat depression in primary care, based on the National Institute
for Health and Care (NICE) guidelines [23]. The training mostly
dealt with the appropriate use of antidepressants. In case of
suicide risk or severe social dysfunction, or if worsening of
symptoms was detected, patients were referred to mental health
facilities.
Intervention Groups
Smiling is Fun is an Internet-delivered, self-help program for
the treatment of depression, based on similar programs that have
proven effective in other countries [24]. The program consists
of 10 cognitive behavioral therapy modules, covering different
psychological techniques for coping with depression. These
modules need to be completed in a sequential way. The program
recommends working on every module for at least a week, with
the following modules: (1) Medication management
(psychoeducation I), (2) Sleep hygiene (psychoeducation II),
(3) Motivation for change (motivation), (4) Understanding
emotional problems (psychoeducation III), (5) Learning to move
on (behavioural activation), (6) Learning to be flexible
(cognitive therapy), (7) Learning to enjoy (positive psychology
I), (8) Learning to live (positive psychology II), (9) Living and
learning (positive psychology III), and (10) From now on, what
else? (relapse prevention). A more specific and detailed
description of the module contents can be found elsewhere
[16,17].
Patients in the intervention groups were allocated to LITG or
to CSG Internet-based programs. In LITG, 4 trained
psychotherapists randomly contacted the patients by email to
offer help with any difficulties or problems encountered when
using the program. Patients could ask the psychotherapists
questions or advice via email messages with a maximum of
three contacts over the treatment period. They could also ask a
technician for help to resolve problems of a technical nature. In
CSG, there was no contact with any therapist, and only technical
questions could be asked regarding the computer program.
To maximize adherence, if participants did not access the
program for a week, they received an automated email
encouraging them to use the program and to complete the tasks
for each module. In addition, the program offered continuous
feedback to the users on their progress via (1) a self-monitored
activity report, providing feedback on how their mood was
related to the activities performed, (2) the calendar, providing
feedback about homework and tasks already completed, and (3)
graphs and other feedback about activity levels, emotional
distress, and negative and positive emotionality.
Among those patients on medication, GPs and patients were
advised not to increase dosages in any of the three groups
(iTAU, CSG, LITG), but decreasing medication was permitted.
Instruments
Demographic Variables
We gathered sociodemographic data such as age, sex, living
with family or alone, level of studies (university vs secondary
or less), employment (employed vs unemployed), and income
according to national minimum wage, as well as clinical
variables such as taking antidepressant medication (yes vs no)
and the number of GP visits in the previous 12 months.
Outcomes
The Spanish version of BDI-II [19], as a continuous variable,
was used as the primary outcome measure at time 1 (3 months
after baseline). The BDI-II is one of the most widely used
instruments to evaluate presence and severity of depressive
symptoms. It is a self-reported measure, which includes the
cardinal cognitive, emotional, and somatic symptoms of
depression, and it can be linked to diagnosis from the DSM-IV.
The studies published show good agreement between BDI-II
and the clinical diagnosis of depression, and good psychometric
properties for the scale [25,26]. Scores can range from 0-63.
Secondary outcomes included the visual analogue scale (VAS)
of the EuroQol (EQ-5D) [27], in its Spanish version [28], and
the Short Form Health Survey (SF-12v1) [29], in its Spanish
version [30], as measures of health-related quality of life and
functioning. The VAS is a vertical line on which the best and
worst possible health states are scored 100 or zero respectively.
The SF-12 scoring algorithm yields a physical component scale
and a mental component scale, and both were used as continuous
variables applying Spanish norms, with a mean of 50 (SD 10)
[30].
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Sample Size
Estimated sample size in protocol was 450 participants [16],
but there were recruitment problems in one of the four
participant regions, Valencia, where there were multiple
stakeholders, so the recruitment was delayed for more than one
year. In view of this, the steering committee of the project
decided to rule out recruitment in that region, repeating the
process of sample size calculation, according to the new
situation. This new power calculation was based on testing
differences between LITG Internet-based program and iTAU
care alone, and we based our sample size estimation on an
expected difference in the primary outcome of at least 0.5
standard deviation (SD) [14]. This size has been considered as
a clinically relevant criterion [24,31]. Previous PC studies of
depressed patients in England and Spain have found BDI-II
means and SDs of 22 and 12, respectively, but as our inclusion
cut-off points attenuate variability, we used an SD of 6. Thus,
a difference of 3 points across these two groups was our target
(around 15%). In order to detect this difference between LITG
and iTAU, assuming a common SD of 6 points, a 5%
significance level and a statistical power of 80%, we needed 63
subjects in each group. We expected a dropout rate of around
30% [12,32], so we inflated the numbers to reach a total sample
size of around 300 patients (100 per arm). This change in the
number of participants was more realistic for the new situation
of recruitment.
Data Analysis
First, descriptive data were compared to assess the balance of
a number of variables across arms at baseline. All analyses
followed a pre-specified plan [16], based on the Consolidated
Standards of Reporting Trial (CONSORT) guidelines [33]
(Multimedia Appendix 1). The primary between-group analysis
was carried out on an intention-to-treat basis for BDI-II total
scores, using a multilevel mixed-effects analysis for repeated
measures, and calculating regression coefficients (B), unadjusted
and adjusted for baseline scores, sex, and age [34]. Sensitivity
analyses were conducted to assess the effects of missing data.
Missing values were replaced by multiple imputations based
on chained equations, after ensuring that data were missing at
random [35]. Secondary analysis comprised comparisons of
SF-12 Mental and Physical subscale scores, as well as EuroQol
VAS scores using the same analytical strategy. Effect sizes
between groups were calculated by means of Hedge’s g, and
group by time interactions (3 groups and 4 time points) through
chi-square tests, unadjusted and adjusted for baseline, sex, and
age, with the associated degrees of freedom of (r-1) x (c-1),
where r is the number of groups and c is the number of time
points. We also performed a Complier Average Causal Effect
(CACE) analysis to assess the impact of the number of sessions
on the outcome. We theoretically defined compliance as
attendance at >6 sessions, but we also performed a parallel
assessment of the impact for each session added separately.
We used two-sided tests at the 5% significance level, taking
into account Bonferroni’s criterion whenever there were multiple
comparisons. All the analyses were performed with Stata 12.
Results
A total of 46 GPs took part in the study. Of 397 potential
participants, 296 were randomized (see Figure 1), with 102
allocated to iTAU, 98 to the CSG, and 96 to the LITG. The
randomized groups were well balanced in all variables at
baseline (Table 1). Recruitment varied across regions: 126
participants from Aragon, 106 from Andalusia, 44 from the
Balearic Islands, and 20 from Valencia. Follow-up primary
outcome data were obtained for 239 (80.7%) of the participants
at Time 1, 210 (70.9%) at Time 2, and 203 (68.6) at Time 3.
There were no significant differences among groups in terms
of attrition rate (iTAU=34.3%; CSG=41.8%; LITG=33.3%;
χ22=0.42; P=.812). Only age was significantly related to attrition
(at Time 3) [completers (n=203): mean 44.28 years (SD 10.22)
vs missing (n=93): mean 39.99 years (SD 10.01); P=.001]. No
baseline-level differences in other sociodemographic or primary
or secondary outcomes were observed between completers and
non-completers at different waves, so dropouts were considered
as to be random [36]. The median depression severity across
all groups in BDI-II at baseline was 23, which broadly equated
with a depression of moderate severity [20].
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Table 1. Baseline characteristics of participants across groups.
LITG, n=96CSG, n=98iTAU, n=102Characteristics at baseline
Sociodemographics
43.19 (9.30)42.57 (11.94)43.04 (9.66)Age, mean (SD)
76 (79.2)72 (73.5)76 (74.5)Sex female, n (%)
82 (85.4)90 (91.8)92 (90.2)Living with family, n (%)
32 (33.3)29 (29.6)30 (29.4)University education, n (%)
52 (54.2)51 (52.0)54 (52.9)Employed, n (%)
Income, n (%)
22 (22.9)34 (34.7)27 (26.5)<1 national minimum wage
40 (41.7)33 (33.7)42 (41.2)1-2 national minimum wage
34 (35.4)31 (31.6)33 (32.4)≥3 national minimum wage
88 (91.7)84 (85.7)91 (89.2)On medication, n (%)
5 (3-8)5 (3-10)5 (2-8)Number of GP visits, median (Q1-Q3)
Clinical measures
Depression severity
22.36 (4.91);
23 (14-28)
22.33 (4.85);
23 (14-28)
22.18 (5.25);
23 (14-28)
BDI-II, mean (SD);
median (Min to Max)
Perceived health
56.04 (18.34);
60 (0-100)
55.45 (19.23);
50 (10-100)
57.04 (15.77);
57 (20-90)
EuroQol VAS, mean (SD); median
(Min to Max)
48.60 (11.16);
50.99 (26.12-66.43)
48.52 (11.61);
49.87 (16.76-65.59)
48.87 (11.26);
49.47 (23.52-66.60)
Physical Health SF-12, mean (SD); median
(Min to Max)
28.60 (8.91);
26.83 (14.09-56.09)
28.03 (9.33);
26.16 (5.53-56.02)
28.71 (10.43);
26.68 (10.51-55.69)
Mental Health SF-12, mean (SD);
median (Min to Max)
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Figure 1. Flow diagram.
Primary Analyses
There were no clear differences between either CSG or LITG
compared with iTAU at Time 1 (Table 2). However, there were
differences between iTAU versus CSG, and iTAU versus LITG
at Time 2 and at Time 3, with both computerized interventions
performing better than usual care. There were no significant
differences between CSG and LITG at any time. The adjusted
models confirmed these findings (Table 2). Models with missing
values replaced through multiple imputations showed small
reductions in regression coefficients, but the main differences
remained unaltered: Time 2, iTAU vs CSG (B=-2.91; P<.001);
iTAU vs LITG (B=-3.97; P<.001); Time 3, iTAU vs CSG
(B=-3.69; P<.001); iTAU vs LITG (B=-4.26; P<.001). In
keeping with the above results, there was a significant group x
time interaction (unadjusted: χ26=19.23; P=.003; adjusted:
χ26=21.27; P=.001; imputed: χ
2
6=343.16; P<.001). The CACE
analysis and the estimated additional intervention effect per
J Med Internet Res 2016 | vol. 18 | iss. 8 | e231 | p.6http://www.jmir.org/2016/8/e231/
(page number not for citation purposes)
Montero-Marín et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
sessions attended also showed there was an additional benefit with more sessions attended (Table 4).
Table 2. Primary outcome analysis with observed dataa.
B
(95% CI)
(b-c)
P
(b-c)
g
(b-c)
B
(95% CI)
(a-c)
P
(a-c)
g
(a-c)
B
(95% CI)
(a-b)
P
(a-b)
g
(a-b)
LITG (c)
mean (SD)
CSG (b)
mean (SD)
iTAU (a)
mean (SD)
n=64n=57n=67BDI-II
21.73
(4.83)
22.59
(4.78)
21.76
(5.39)
Time 0
0.44
(-2.45
to 3.34)
.764-0.05-0.71
(-3.61
to 2.20)
.6340.08-1.15
(-4.08
to 1.79)
.4440.1217.08
(10.24)
16.59
(10.60)
17.91
(11.06)
Time 1
0.61
(-2.23
to 3.45)
.674-0.74
(-3.60
to 2.12)
.613-1.35
(-4.23
to 1.54)
.359Adjusted
-0.12
(-3.14
to 2.90)
.9380.07-4.34
(-7.36
to -1.33)
.0050.38-4.22
(-7.28
to -1.16)
.0070.3413.56
(11.56)
14.27
(10.00)
18.12
(12.15)
Time 2
0.26
(-2.70
to 3.22)
.862-4.31
(-7.27
to -1.35)
.004-4.55
(-7.56
to -1.55)
.003Adjusted
0.48
(-2.57
to 3.54)
.7580.01-4.62
(-7.66
to -1.58)
.0030.48-5.10
(-8.20
to -1.99)
.0010.4811.39
(10.96)
11.53
(10.72)
16.72
(10.97)
Time 3
0.86
(-2.14
to 3.85)
.574-4.62
(-7.61
to -1.63)
.002-5.47
(-8.51
to -2.42)
<.001Adjusted
ag: Hedge’s g as an effect size measure; B: regression coefficients; adjusted: adjusted analysis controlling baseline, sex, and age; a-b: iTAU vs CSG
comparison; a-c: iTAU vs LITG comparison; b-c: CSG vs LITG comparison.
Secondary Analyses
Results with the Mental SF-12 showed a similar pattern of
differences as in the primary outcome (Table 3). Analysis with
imputed values attenuated coefficients but the main differences
were maintained: Time 2, iTAU vs CSG (B=4.79; P<.001);
iTAU vs LITG (B=4.76; P<.001); Time 3, ITAU vs CSG
(B=4.63; P<.001); iTAU vs LITG (B=5.54; P<.001)]. Similarly,
group x time interactions were observed (unadjusted: χ26=27.05;
P<.001; adjusted: χ26=31.01; P<.001; imputed: χ
2
6=422.56;
P<.001), and there were also dose-response effects associated
with the number of sessions (Table 4). There were no differences
across arms for Physical SF-12 at any time (Table 3). Some
differences were found between iTAU vs LITG at Time 2 and
Time 3 when using EUROQOL (Table 3), which were confirmed
with adjusted and imputed models: imputed Time 1: B=2.49;
P<.001; Time 2: B=7.26; P<.001; Time 3: B=7.66; P<.001. At
Time 3, there were also EUROQOL differences between iTAU
vs CSG in the adjusted model. Using imputed data, these
differences were also seen at earlier times (Time 2: B=3.78;
P<.001; Time 3: B=5.30; P<.001). When imputing values, we
also found differences between CSG vs LITG at Time 1
(B=2.75; P<.001), Time 2 (B=3.48; P<.001), and Time 3
(B=2.35; P<.001). Group x time effects were not found with
unadjusted data (χ26=11.10; P=.085), but there were interactions
with the adjusted (χ26=12.88; P=.045) and imputed (χ
2
6=219.54;
P<.001) models. Dose-response effects were also found (Table
4).
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Table 3. Secondary outcome analyses with observed dataa.
B (95% CI)
(b-c)
P
(b-c)
g
(b-c)
B (95% CI)
(a-c)
P
(a-c)
g
(a-c)
B (95% CI)
(a-b)
P
(a-b)
g
(a-b)
LITG (c)
mean (SD)
CSG (b)
mean (SD)
iTAU (a)
mean (SD)
n=64n=55n=64Mental SF-12
27.95
(8.78)
28.59
(8.90)
29.13
(11.18)
Time 0
2.63
(-1.54
to 6.80)
.216-0.180.85
(-3.20
to 4.89)
.682-0.13-1.83
(-5.91
to 2.25)
.3800.0636.97
(12.57)
34.72
(12.46)
35.41
(12.19)
Time 1
3.01
(-1.06
to 7.07)
.1871.10
(-2.87
to 5.06)
.589-1.94
(-5.94
to 2.06)
.341Adjusted
-0.56
(-4.89
to 3.78)
.8010.015.97
(1.80
to 10.13)
.005-0.486.49
(2.26
to 10.72)
.003-0.5342.22
(13.24)
42.35
(11.03)
36.05
(12.38)
Time 2
-0.37
(-4.59
to 3.85)
.8636.41
(2.33- 10.49)
.0026.67
(2.53
to 10.81)
.002Adjusted
-0.28
(-4.69
to 4.12)
.901-0.026.53
(2.29
to 10.76)
.003-0.576.78
(2.46
to 11.11)
.002-0.5943.65
(13.41)
43.44
(11.66)
36.35
(12.12)
Time 3
-0.03
(-4.31
to 4.25)
.9897.09
(2.95
to 11.24)
.0017.03
(2.80
to 11.26)
.001Adjusted
n=64n=55n=64Physical SF-
12
47.98
(10.87)
47.83
(12.29)
48.74
(11.67)
Time 0
-0.44
(-3.26 –
2.38)
.760-0.030.69
(-2.17 – 3.54)
.638-0.121.13
(-1.76 – 4.02)
.443-0.0849.20
(10.58)
48.84
(11.89)
47.91
(10.31)
Time 1
-0.35
(-3.02 –
2.33)
.7990.85
(-1.89 – 3.60)
.5421.23
(-1.53 – 4.00)
.382Adjusted
-0.52
(-3.46 –
2.41)
.7270.05-0.18
(-3.13
to 2.77)
.9060.060.35
(-2.66
to 3.35)
.8200.0146.87
(10.79)
47.42
(12.18)
47.56
(10.74)
Time 2
-0.49
(-3.27 –
2.28)
.7270.10
(-2.72
to 2.92)
.9460.61
(-2.26
to 3.47)
.677Adjusted
0.42
(-2.56
to 3.41)
.781-0.040.68
(-2.32
to 3.68)
.655-0.050.27
(-2.81
to 3.34)
.864-0.0148.05
(9.85)
47.65
(11.89)
47.53
(11.78)
Time 3
0.45
(-2.37
to 3.27)
.7550.73
(-2.14
to 3.59)
.6200.32
(-2.61
to 3.25)
.830Adjusted
n=65n=57n=66EuroQol
VAS
57.46
(18.23)
53.56
(20.05)
57.80
(15.81)
Time 0
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B (95% CI)
(b-c)
P
(b-c)
g
(b-c)
B (95% CI)
(a-c)
P
(a-c)
g
(a-c)
B (95% CI)
(a-b)
P
(a-b)
g
(a-b)
LITG (c)
mean (SD)
CSG (b)
mean (SD)
iTAU (a)
mean (SD)
2.24
(-4.19
to 8.66)
.495-0.132.55
(-3.61
to 8.70)
.418-0.190.30
(-5.91
to 6.52)
.924-0.0565.85
(21.34)
63.11
(21.61)
62.12
(18.12)
Time 1
1.94
(-4.28
to 8.17)
.5412.66
(-3.33
to 8.64)
.3850.71
(-5.32
to 6.75)
.816Adjusted
2.99
(-3.70
to 9.68)
.381-0.197.73
(1.38
to 14.09)
.016-0.364.73
(-1.73
to 11.19)
.152-0.1669.83
(20.21)
65.81
(21.44)
62.33
(20.83)
Time 2
2.34
(-4.13
to 8.81)
.4787.84
(1.68
to 14.01)
.0135.45
(-0.81
to 11.71)
.088Adjusted
0.69
(-6.09
to 7.47)
.842-0.188.10
(1.65
to 14.54)
.014-0.547.39
(0.82
to 13.97)
.028-0.2972.45
(15.93)
68.89
(22.79)
62.59
(20.37)
Time 3
-0.13
(-6.68
to 6.43)
.9708.19
(1.95
to 14.44)
.0108.31
(1.94
to 14.44)
.011Adjusted
ag: Hedge’s g as an effect size measure; B: regression coefficients; adjusted: adjusted analysis controlling baseline, sex, and age; a-b: iTAU vs CSG
comparison; a-c: iTAU vs LITG comparison; b-c: CSG vs LITG comparison.
Table 4. Dose-response in primary and secondary outcomes.
ImputedcAdjustedbRawaVariables
PBPBPB
BDI-II
<.001-8.07 (-9.42 to -6.72).006-7.24 (-12.33 to -2.15).016-6.93 (-12.52 to -1.33)CACE analysisd
<.001-0.73 (-0.85 to -0.61).006-0.68 (-1.16 to -0.20).015-0.65 (-1.18 to -0.13)Effect per session
Mental SF-12
<.00110.59 (9.05 to 12.12).00110.27 (4.01 to 16.52).0049.42 (3.08 to 15.75)CACE analysisd
<.0010.95 (0.82 to 1.09).0010.97 (0.38 to 1.56).0040.89 (0.29 to 1.48)Effect per session
Physical SF-12
.6760.29 (-1.07 to 1.64).7760.65 (-3.85 to 5.16).9960.01 (-5.71 to 5.74)CACE analysisd
.6760.03 (-0.10 to 0.15).7750.06 (-0.36 to 0.49).996<1.01 (-0.54 to 0.54)Effect per session
EuroQol VAS
<.00113.12 (10.58 to 15.66).01712.18 (2.22 to 22.13).03611.44 (0.76 to 22.12)CACE analysisd
<.0011.18(0.96 to 1.41).0161.15 (0.22 to 2.07).0341.08 (0.08 to 2.07)Effect per session
aUsing raw models.
bAdjusting baseline, sex and age.
cUsing imputed data.
dCompliance as attendance at >6 sessions. B: regression coefficients. Controls were considered as receiving 0 sessions.
Internet-Based Program Usage
At Time 3, 72.4% (n=71) of CSG participants and 75.0% (n=72)
of LITG participants had accessed the Internet-based programs
(χ21=0.35; P=.556). In CSG, the median number of modules
completed was 4 (interquartile range: 0-10), with 41.8%
attending >6 modules; 30 participants in this group completed
sessions. In LITG, the median number of modules completed
was 6 (interquartile range: 0-10), with 50.0% attending >6
modules and 40 participants completing 10 modules. There was
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no significant difference between CSG and LTIG in terms of
modules completed (Z=-1.20; P=.228). A total of 17 email
contacts were made with 13 participants of the LITG program,
which represented 11.9% of the patients in this group. Support
requests were monitored, and a content analysis of them showed
that the topics were related to (1) requesting information on
depressive symptoms, (2) counseling with regard to events and
difficulties in life, and (3) additional support to follow the
program recommendations. As per protocol, CSG received no
email contact from therapists.
Other Treatments Received
Most of the participants received drug treatment (Table 1). There
were no major differences in the use of medication (as a
dichotomous criterion of drug intake) across groups (iTAU:
80.6%; CSG: 68.3%; LITG: 67.6%; χ22=3.67; P=.160). The
same pattern was found for the use of mental health services,
psychiatrist and/or psychologist (iTAU: 29.9%; CSG: 19.7%;
LITG: 18.8%; χ22=3.09; P=.214), and number of visits to the
GP [iTAU: median=2 (Q1=0; Q3=4); CSG: median=1 (Q1=0;
Q3=3); LITG: median=1 (Q1=0; Q3=4); χ
2
2=0.22; P=.643].
Discussion
Principal Findings
As far as we are aware, this is the first RCT on the effectiveness
of an Internet-based intervention for the treatment of depression
in PC health services in Spain. Other Web-based interventions
for treating depressive symptoms in the Spanish language have
been developed in Mexico [37] and Chile [38], but the efficacy
of these interventions in reducing depressive symptoms has not
yet been evaluated in an RCT. Therefore, this trial is novel in
that it allowed the testing of a new Spanish program (Smiling
is Fun), which adapted some of the techniques used in other
available programs [24,39]. This trial compared two
Internet-based interventions, with and without psychotherapeutic
support, with usual care. We observed differences in the medium
and long term in favor of psychotherapy, but not in the short
term. This was somewhat consistent with previous studies on
depression when comparing face-to-face psychotherapy (alone
or plus usual care), with usual care based on medication
treatments [40]. We found a larger effect size than in previous
works, particularly in the group without additional support, and
we also found that the offer of support did not yield additional
benefits in terms of better adherence or outcomes, contrary to
other previously published studies [41,42].
The way patients were recruited in PC settings, with face-to-face
contacts in a confidential context with the involvement of the
GP, might explain why our results were better than those of
other trials [14]. Studies in which patients suffering from
depression were referred by their GP for treatment had generally
shown higher effect sizes, with values similar to our study [5].
This aspect of the trial may have also contributed to the low
number of email contacts requesting assistance to the
psychotherapists, and therefore, to the similarity in the results
for the supported and the unsupported groups. This same result
has also been found in other works [15], although effect sizes
in Internet-based interventions with therapist support typically
seem larger than those without therapist support [14]. In our
study, the type of support received by email on request was less
intense than in other efficacy trials, which additionally include
a group with some kind of weekly contact [14,15]. Patients in
our study did not make much use of the support offered. We do
not know the real reasons for this, but the lack of initial
face-to-face contact with the psychotherapist might have
hampered the establishment of an adequate alliance—something
that might merit interest for further studies [19].
The possibility of receiving attention and care from a GP in a
PC setting could also help minimize the stigma associated with
referral to mental health services [11] and could improve
adherence to the program. In fact, our procedure was as close
as possible to the usual practice, and thus, it might increase the
likelihood that the program might be used in the PC health
services in Spain, where most depressed patients are treated
[43]. Nevertheless, GPs may experience difficulties in recruiting
patients because of their overloaded schedule, as has been
described in other countries [44].
Limitations
This study encountered several limitations. First, attrition at
follow-up was significant, but replacing missing values through
imputations confirmed the main findings. As shown in other
similar trials of computerized interventions, attrition rates are
often large [12,32]. If anything, our retention rate was probably
as good, if not better, than that achieved in other similar trials.
Second, the potential effect of GPs or psychotherapist was not
taken into account and may have been a source of variability.
Finally, this trial was not powered to detect small differences
between the two computerized interventions. This part of the
study needs to be tested properly in a separate trial also
controlling for the possible effects of psychotherapists and GPs.
Conclusions
A Spanish-language Internet-based intervention for the treatment
of depression (Smiling is Fun) added to usual care proved to be
more effective than treatment as usual alone at follow-up
assessments. Pending cost-effectiveness analysis, these results
suggest that it might be worth investing in this program for PC
clinics in Spain, and possibly in other Spanish-speaking settings.
The kind of low-intensity support offered in the program did
not show additional improvement on the effectiveness of the
computerized intervention. It remains to be seen whether or not
any other forms of online/telephone support might yield further
gains.
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